The Global Automated and Closed Cell Therapy Processing Systems Market is Predict to reach $37.9 billion by 2027, at a CAGR of 32.3%

Automated and Closed Cell Therapy Processing Systems Market Growth, Trends and Report Highlights

According to a new report Global Automated And Closed Cell Therapy Processing Systems Market, published by KBV research, The Global Automated And Closed Cell Therapy Processing Systems Market size is expected to reach $2,247.8 Million by 2027, rising at a market growth of 20.3% CAGR during the forecast period.

The separation workflow is anticipated to witness the fastest growth rate over the forecast period. The cell separation procedure is performed across numerous cellular experiments like production of hybridomas, cellular genetic modification, molecular analysis, and other cell research & analysis-regarding applications. The rise in the number of research activities for such applications in academic universities & other research institutions is estimated to fuel the growth of the segment.

The stem cell therapy segment is estimated to display a promising CAGR over the forecast period. Some of the growth factors for the segment are growing awareness among end-users regarding therapeutic benefits provided by stem cell therapies and increasing research activities regarding drug efficacy and understanding disease.

The commercial-scale segment is anticipated to showcase the fastest growth rate over the forecast period. The growing prevalence of chronic diseases like cancer is motivating companies to develop advanced cell-therapy-based therapeutic platforms. In addition, the key players are also majorly aiming at cost optimization, which is estimated to support the growth of the segment.

The North America market dominated the Global Automated and Closed Cell Therapy Processing Systems Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $983.8 million by 2027.

Full Report: https://www.kbvresearch.com/automated-and-closed-cell-therapy-processing-systems-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of SoftBank Group Corporation, NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Hanson Robotics Limited, KUKA AG, Xilinx, Inc., ABB Group, and FANUC Corporation.

Global Automated and Closed Cell Therapy Processing Systems Market Segmentation

By Type

• Separation
• Expansion
• Apheresis
• Fill-Finish
• Cryopreservation

By Workflow

• Stem Cell Therapy
• Non-Stem Cell Therapy

By Scale

• Pre-commercial/R&D Scale
• Commercial Scale

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Lonza Group AG
• Terumo Corporation
• Cytiva (Danaher Corporation)
• Thermo Fisher Scientific, Inc.
• Miltenyi Biotec B.V. & Co. KG
• Thermogenesis Holdings, Inc.
• Cellares Inc.
• Biospherix ltd.
• Sartorius AG
• Fresenius SE & Co. KGaA

Related Reports:

North America Automated and Closed Cell Therapy Processing Systems Market Size, 2027

• December-2021
• 86 Pages

LAMEA Automated and Closed Cell Therapy Processing Systems Market Size, 2027

• December-2021
• 98 Pages

Europe Automated and Closed Cell Therapy Processing Systems Market Size, 2027

• December-2021
• 99 Pages

Asia Pacific Automated and Closed Cell Therapy Processing Systems Market Size, 2027

• December-2021
• 101 Pages